Anatomical Colocalization of Vitiligo and Alopecia Areata

Alopecia areata (AA) and vitiligo are two common disorders in general population and coincidence of these two diseases is thus to be expected. However, anatomical coexistence of both conditions had rarely been reported. Many different etiological hypotheses have been suggested for both diseases. While alopecia areata is considered a T-cell medi- ated autoimmune disease, in the pathogenesis of vitiligo, both T cells and autoantibodies may play a role. Here we report a case which supports the hypothesis that vitiligo-induced autoimmunity could trigger AA and bulb melanocytes could act as a possible target in AA. We report the case of a 53-year-old woman which was referred to Dermatology Department for treatment of AA. Twenty years previously, she had developed areas of vitiligo on the face and arms which remained stable for years. She presented with a 1-year history of alopecia on the scalp, with a loss of skin and hair color in the same location during this period. In our case, the chronological appearance, association and co-localization of vitiligo and AA could emphasize the hypothesis that melanocytes-derived antigens released during vitiligo pathogenesis could act as auto-antigens, inducing hair loss.

[1]  P. Itin,et al.  Disorders of Pigmentation , 2009, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  C. Melief,et al.  Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. , 2009, The Journal of investigative dermatology.

[3]  R. Spritz,et al.  Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff , 2009, Experimental dermatology.

[4]  R. Spritz The genetics of generalized vitiligo and associated autoimmune diseases. , 2007, Pigment cell research.

[5]  P. Christos,et al.  Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  D. Zillikens,et al.  Mechanisms of blister induction by autoantibodies , 2005, Experimental dermatology.

[7]  N. Rezaei,et al.  Assessment of the immune system in 55 Iranian patients with vitiligo , 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  W. Du,et al.  Clinical profiles of vitiligo in China: an analysis of 3742 patients , 2005, Clinical and experimental dermatology.

[9]  S. Dogra,et al.  Late onset vitiligo: A study of 182 patients , 2005, International journal of dermatology.

[10]  J. Sinagra,et al.  Relevance of Thyroiditis and of Other Autoimmune Diseases in Children with Vitiligo , 2004, Dermatology.

[11]  V. Barišić-Druško,et al.  Trigger factors in childhood psoriasis and vitiligo. , 2004, Collegium antropologicum.

[12]  L. Ersoy,et al.  Association of vitiligo, morphea, and Hashimoto's thyroiditis , 2004, International journal of dermatology.

[13]  A. Gilhar,et al.  Alopecia areata: autoimmunity--the evidence is compelling. , 2003, The journal of investigative dermatology. Symposium proceedings.

[14]  Torello Lotti,et al.  The neuro‐immuno‐cutaneous‐endocrine network: relationship between mind and skin , 2003, Dermatologic therapy.

[15]  S. Dogra,et al.  Epidemiology of Childhood Vitiligo: A Study of 625 Patients from North India , 2003, Pediatric dermatology.

[16]  B. Marinovic,et al.  Coexistence of psoriasis vulgaris, bullous pemphigoid and vitiligo: a case report , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  M. Landau,et al.  Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. , 2001, The Journal of investigative dermatology.

[18]  K. Midthjell,et al.  Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). , 2000, European journal of endocrinology.

[19]  D. Eisen,et al.  Disorders of pigmentation in the oral cavity. , 2000, Clinics in dermatology.

[20]  A. Lucky,et al.  Colocalization of Alopecia Areata and Vitiligo , 2002, Pediatric dermatology.

[21]  J. Perheentupa,et al.  Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I. , 1999, The Journal of investigative dermatology.

[22]  M. Lakomek,et al.  Autoimmune thyreoiditis in childhood--epidemiology, clinical and laboratory findings in 61 patients. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[23]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[24]  S. Hann,et al.  Segmental vitiligo: clinical findings in 208 patients. , 1996, Journal of the American Academy of Dermatology.

[25]  J. Sánchez,et al.  ORGAN‐SPECIFIC AUTOANTIBODIES IN VITILIGO PATIENTS AND THEIR RELATIVES , 1996, International journal of dermatology.

[26]  A. Kanwar,et al.  COLOCOLIZATION OF VITILIGO AND ALOPECIA AREATA , 1994 .

[27]  L. Hegedüs,et al.  High frequency of thyroid dysfunction in patients with vitiligo. , 1994, Acta dermato-venereologica.

[28]  S. Dhar,et al.  Colocalization of vitiligo and alopecia areata. , 1994, Pediatric dermatology.

[29]  R. Paus,et al.  Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? , 1993, The Yale journal of biology and medicine.

[30]  J. Koo,et al.  PROFILE OF ALOPECIA AREATA: A QUESTIONNAIRE ANALYSIS OF PATIENT AND FAMILY , 1992, International journal of dermatology.

[31]  Y. Shong,et al.  Vitiligo in autoimmune thyroid disease. , 1991, Thyroidology.

[32]  D. Tobin,et al.  Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. , 1990, The Journal of investigative dermatology.

[33]  M. Manns,et al.  Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. , 1990, Journal of hepatology.

[34]  J. Bystryn,et al.  Serum antibodies in vitiligo patients. , 1989, Clinics in dermatology.

[35]  W. Brenner,et al.  Coincidence of vitiligo, alopecia areata, onychodystrophy, localized scleroderma and lichen planus. , 1979, Dermatologica.

[36]  M. Kutner,et al.  Alopecia areata and vitiligo associated with Down's syndrome. , 1977, Archives of dermatology.

[37]  Behl Pn,et al.  400 cases of vitiligo. A clinico-therapeutic analysis. , 1972 .

[38]  P. Behl,et al.  400 cases of vitiligo. A clinico-therapeutic analysis. , 1972, Indian journal of dermatology.